Promising response to vemurafenib and cobimetinib treatment for BRAF V600E mutated craniopharyngioma: a case report and literature review

Nina Yu1 University of California, Davis School of Medicine, Sacramento, CA, USA

https://orcid.org/0000-0002-2387-2093

Osama A Raslan2 Department of Radiology, Division of Neuroradiology, University of California Davis, Sacramento, CA 95817, USA

Han Sung Lee3 Department of Pathology, University of California Davis, Sacramento, CA 95817, USA

Brett J Theeler4 Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA

Tarek A Raafat5 Department of Radiology, National Cancer Institute, Cairo University, Cairo, Egypt

Ruben Fragoso6 Department of Radiation Oncology, University of California, Davis, Sacramento, CA 95817, USA

Kiarash Shahlaie7 Department of Neurological Surgery, University of California, Davis, Sacramento, CA 95817, USA

Orwa Aboud7 Department of Neurological Surgery, University of California, Davis, Sacramento, CA 95817, USA;8 Department of Neurology, University of California, Davis, Sacramento, CA 95817, USA;9 Comprehensive Cancer Center, University of California Davis, Sacramento, CA 95817, USACorrespondence[email protected]

https://orcid.org/0000-0002-7916-1629

show all

Promising response to vemurafenib and cobimetinib treatment for BRAF V600E mutated craniopharyngioma: a case report and literature review

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Promising response to vemurafenib and cobimetinib treatment for BRAF V600E mutated craniopharyngioma: a case report and literature review

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date